Quarterly report · Q3
6323.TEDINET S100PY7W
Period2022-03-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥71.4bn | 2022-03-01 → 2022-11-30 | Cons. | Net sales |
| Revenue | ¥67.0bn | 2021-03-01 → 2022-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥46.6bn | 2021-03-01 → 2021-11-30 | Cons. | Net sales |
| Operating income | ¥17.7bn | 2022-03-01 → 2022-11-30 | Cons. | Operating income |
| Operating income | ¥10.8bn | 2021-03-01 → 2021-11-30 | Cons. | Operating income |
| Ordinary income | ¥26.7bn | 2022-03-01 → 2022-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥17.8bn | 2021-03-01 → 2022-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.0bn | 2021-03-01 → 2021-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥26.7bn | 2022-03-01 → 2022-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥12.8bn | 2021-03-01 → 2021-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥19.7bn | 2022-03-01 → 2022-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥12.8bn | 2021-03-01 → 2022-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥8.7bn | 2021-03-01 → 2021-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥20.6bn | 2022-03-01 → 2022-11-30 | Cons. | Profit loss |
| Net income | ¥9.6bn | 2021-03-01 → 2021-11-30 | Cons. | Profit loss |
| Total assets | ¥126.7bn | at 2022-11-30 | Cons. | Assets |
| Total assets | ¥88.3bn | at 2022-02-28 | Cons. | Assets |
| Total assets | ¥81.1bn | at 2021-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥52.3bn | at 2022-11-30 | Cons. | Liabilities |
| Total liabilities | ¥38.1bn | at 2022-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥74.4bn | at 2022-11-30 | Cons. | Net assets |
| Net assets / equity | ¥50.2bn | at 2022-02-28 | Cons. | Net assets |
| Net assets / equity | ¥45.2bn | at 2021-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥30.0bn | at 2022-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥23.6bn | at 2022-02-28 | Cons. | Cash and deposits |
| EPS (basic) | ¥1,138.05 | 2022-03-01 → 2022-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥422.44 | 2022-09-01 → 2022-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥742.1 | 2021-03-01 → 2022-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥504.34 | 2021-03-01 → 2021-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥186.14 | 2021-09-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥1,135.91 | 2022-03-01 → 2022-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥740.72 | 2021-03-01 → 2022-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥503.42 | 2021-03-01 → 2021-11-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 54.0% | at 2022-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 51.4% | at 2022-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.0% | at 2021-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-03-01 → 2022-11-30 | −¥14m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-03-01 → 2022-11-30 | −¥14m |
| Reconciling Itemsreconciling | segment profit | 2022-03-01 → 2022-11-30 | −¥495m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue | 2022-03-01 → 2022-11-30 | ¥248m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue external | 2022-03-01 → 2022-11-30 | ¥248m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | segment profit | 2022-03-01 → 2022-11-30 | −¥116m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2022-03-01 → 2022-11-30 | ¥71.1bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2022-03-01 → 2022-11-30 | ¥71.1bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2022-03-01 → 2022-11-30 | ¥14m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2022-03-01 → 2022-11-30 | ¥18.4bn |
| —segment total | revenue | 2022-03-01 → 2022-11-30 | ¥71.4bn |
| —segment total | revenue external | 2022-03-01 → 2022-11-30 | ¥71.4bn |
| —segment total | revenue intersegment | 2022-03-01 → 2022-11-30 | ¥14m |
| —segment total | segment profit | 2022-03-01 → 2022-11-30 | ¥18.2bn |
| Reconciling Itemsreconciling | revenue | 2021-03-01 → 2021-11-30 | −¥17m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-03-01 → 2021-11-30 | −¥17m |
| Reconciling Itemsreconciling | segment profit | 2021-03-01 → 2021-11-30 | −¥309m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue | 2021-03-01 → 2021-11-30 | ¥395m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | revenue external | 2021-03-01 → 2021-11-30 | ¥395m |
| jpcrp040300-q3r_E02328-000Life Sciencereportable segment | segment profit | 2021-03-01 → 2021-11-30 | −¥42m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue | 2021-03-01 → 2021-11-30 | ¥46.2bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue external | 2021-03-01 → 2021-11-30 | ¥46.2bn |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | revenue intersegment | 2021-03-01 → 2021-11-30 | ¥17m |
| jpcrp040300-q3r_E02328-000Semiconductor And Liquid Crystalreportable segment | segment profit | 2021-03-01 → 2021-11-30 | ¥11.1bn |
| —segment total | revenue | 2021-03-01 → 2021-11-30 | ¥46.6bn |
| —segment total | revenue external | 2021-03-01 → 2021-11-30 | ¥46.6bn |
| —segment total | revenue intersegment | 2021-03-01 → 2021-11-30 | ¥17m |
| —segment total | segment profit | 2021-03-01 → 2021-11-30 | ¥11.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 356
| Item | Context | Value | Unit |
|---|---|---|---|
| Extraordinary loss | CurrentYTDDuration | 5000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 12817000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 26658000000 | JPY |
| Income taxes current | Prior1YTDDuration | 3961000000 | JPY |
| Income taxes current | CurrentYTDDuration | 6007000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | -716000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 69000000 | JPY |
| Income taxes | Prior1YTDDuration | 3245000000 | JPY |
| Income taxes | CurrentYTDDuration | 6077000000 | JPY |
| Profit loss | Prior1YTDDuration | 9572000000 | JPY |
| Profit loss | CurrentYTDDuration | 20580000000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 857000000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 913000000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 8715000000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 19666000000 | JPY |
| Profit loss | Prior1YTDDuration | 9572000000 | JPY |
| Profit loss | CurrentYTDDuration | 20580000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | 59000000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 9000000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 1402000000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 5303000000 | JPY |
| Other comprehensive income | Prior1YTDDuration | 1461000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 5312000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 11034000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 25893000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 10188000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 24766000000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 846000000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 1127000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 46195000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | 395000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 46591000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 46591000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 17000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 17000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -17000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 46213000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | 395000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 46608000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -17000000 | JPY |
| Net sales | Prior1YTDDuration | 46591000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 11126000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E02328-000LifeScienceReportableSegmentsMember | -42000000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | 11084000000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -309000000 | JPY |
| Operating income | Prior1YTDDuration | 10774000000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E02328-000SemiconductorAndLiquidCrystalReportableSegmentsMember | 71134000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |